tiprankstipranks
Kriti Nutrients Limited (IN:KRITINUT)
:KRITINUT
India Market
Want to see IN:KRITINUT full AI Analyst Report?

Kriti Nutrients Limited (KRITINUT) AI Stock Analysis

0 Followers

Top Page

IN:KRITINUT

Kriti Nutrients Limited

(KRITINUT)

Select Model
Select Model
Select Model
Outperform 80 (OpenAI - 5.2)
Rating:80Outperform
Price Target:
₹90.00
▲(14.50% Upside)
Action:Reiterated
Date:05/08/26
The score is driven by strong financial stability (low leverage) and materially improved cash generation, supported by bullish technical trend signals. Valuation also helps due to a low P/E, while the main risk tempering the score is the significant compression in gross and net margins.
Positive Factors
Low leverage / strong balance sheet
Debt-to-equity near 0.04 and rising equity provide durable financial flexibility, lowering refinancing and solvency risk. This conservative capital structure supports investment during commodity cycles, funds working-capital needs, and preserves capacity for capex or opportunistic M&A without stressing liquidity.
Negative Factors
Margin compression
Sustained and material margin erosion over multiple years signals pressure from input costs, spreads or pricing competitiveness. Lower margins reduce return on invested capital, limit reinvestment capacity, and mean higher volume is required to sustain similar profit dollars, raising operational risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
Debt-to-equity near 0.04 and rising equity provide durable financial flexibility, lowering refinancing and solvency risk. This conservative capital structure supports investment during commodity cycles, funds working-capital needs, and preserves capacity for capex or opportunistic M&A without stressing liquidity.
Read all positive factors

Kriti Nutrients Limited (KRITINUT) vs. iShares MSCI India ETF (INDA)

Kriti Nutrients Limited Business Overview & Revenue Model

Company Description
Kriti Nutrients Limited, established in 1992 and headquartered in Indore, India, operates in the manufacturing and global distribution of soybean seeds under its "Kriti" brand. The company's extensive product range includes various edible oils suc...
How the Company Makes Money
Kriti Nutrients Limited primarily makes money by processing agricultural oilseeds and selling the resulting outputs across multiple product streams: (1) Edible oils: revenue is generated from selling refined and/or processed edible oils to wholesa...

Kriti Nutrients Limited Financial Statement Overview

Summary
Strong balance sheet with very low leverage (debt-to-equity ~0.04) and rising equity provides financial flexibility, while cash generation improved sharply in 2026 (free cash flow +61.8% YoY; ~92% of net income). The main offset is meaningful margin compression since 2024 (gross margin down to 8.1% and net margin to 3.7%), indicating profitability pressure despite revenue growth.
Income Statement
68
Positive
Balance Sheet
86
Very Positive
Cash Flow
78
Positive
BreakdownMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue9.22B7.34B6.83B7.96B7.51B
Gross Profit748.03M1.03B1.07B780.37M679.84M
EBITDA434.39M557.89M666.67M356.28M222.83M
Net Income339.01M369.94M452.87M207.98M123.05M
Balance Sheet
Total Assets2.73B2.38B2.09B1.93B1.68B
Cash, Cash Equivalents and Short-Term Investments622.12M265.85M210.43M190.38M37.16M
Total Debt91.01M30.69M121.45M403.73M375.58M
Total Liabilities435.96M259.39M325.25M607.00M554.76M
Stockholders Equity2.29B2.12B1.76B1.32B1.13B
Cash Flow
Free Cash Flow642.82M273.10M409.62M133.43M-193.72M
Operating Cash Flow698.45M319.58M498.13M198.61M-105.10M
Investing Cash Flow-152.65M-288.64M-291.87M-31.35M-199.81M
Financing Cash Flow-100.33M-106.49M-304.01M-14.05M311.86M

Kriti Nutrients Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price78.60
Price Trends
50DMA
87.65
Negative
100DMA
79.16
Negative
200DMA
79.53
Negative
Market Momentum
MACD
-2.16
Positive
RSI
37.73
Neutral
STOCH
21.43
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KRITINUT, the sentiment is Negative. The current price of 78.6 is below the 20-day moving average (MA) of 82.20, below the 50-day MA of 87.65, and below the 200-day MA of 79.53, indicating a bearish trend. The MACD of -2.16 indicates Positive momentum. The RSI at 37.73 is Neutral, neither overbought nor oversold. The STOCH value of 21.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KRITINUT.

Kriti Nutrients Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
₹3.93B11.320.43%25.49%-8.35%
74
Outperform
₹60.99B17.0123.14%50.41%
57
Neutral
₹1.35B14.4232.25%71.27%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
54
Neutral
₹3.98B21.6117.36%24.73%
51
Neutral
₹1.74B25.7743.02%-18.82%
48
Neutral
₹6.82B13.4944.02%12.33%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:KRITINUT
Kriti Nutrients Limited
76.75
-29.52
-27.78%
IN:GOKUL
Gokul Refoils & Solvent Ltd.
40.45
-3.58
-8.13%
IN:GOKULAGRO
Gokul Agro Resources Ltd.
213.00
58.02
37.44%
IN:MKPL
M K Proteins Limited
4.58
-2.71
-37.17%
IN:MUKKA
Mukka Proteins Limited
23.38
-6.58
-21.96%
IN:ROML
Raj Oil Mills Limited
44.80
-10.21
-18.56%

Kriti Nutrients Limited Corporate Events

Kriti Nutrients Promoter Affirms No New Encumbrances on Shares in FY 2025-26
Jun 5, 2026
Sakam Trading Private Limited, a promoter company of Kriti Nutrients Limited, has declared that it and specified members of the promoter group have not created any new encumbrances on the equity shares of Kriti Nutrients during the financial year ...
Kriti Nutrients Publishes Audited FY 2026 Results in Newspapers
May 7, 2026
Kriti Nutrients Limited has published its audited standalone and consolidated financial results for the quarter and full year ended 31 March 2026, and has filed the related newspaper clippings with the stock exchanges. The disclosure, made through...
Kriti Nutrients Files FY26 Audited Results and Financial Statements
May 5, 2026
Kriti Nutrients Limited has submitted its standalone and consolidated audited financial results for the year ended 31 March 2026 to the stock exchange, along with the accompanying audit report, statement of assets and liabilities, and cash flow st...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 08, 2026